Alphabet Inc.

The launch of India’s first indigenous chimeric antigen receptor (CAR)-T cell therapy NexCAR19 (actalycabtagene autoleucel) last month at nearly 10% of the price of similar treatments available in the

[Editor’s note: The story was updated on 14 March to include Verily’s new partnership with WebMD Health Services.] Andrew Trister joined Verily , Alphabet Inc. .’s research organization, as chief sc

In the next five years, people will have their own artificial intelligence “agent” using their own personalized data to help them make health decisions, predicts Andrew Trister, chief medical and scie

The extent to which artificial intelligence (AI) and technology are fundamentally altering the research and development game came through during a panel discussion by Eli Lilly and Company ’s chief i